Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,933
Closed -$751K 1566
2019
Q3
$751K Buy
8,933
+2,800
+46% +$212K 0.04% 685
2019
Q2
$401K Buy
+6,133
New +$353K 0.02% 832
2018
Q4
Sell
-49,729
Closed -$2.98M 1526
2018
Q3
$2.98M Buy
49,729
+21,399
+76% +$1.17M 0.14% 205
2018
Q2
$1.22M Buy
+28,330
New +$1.14M 0.05% 547
2017
Q4
Sell
-19,630
Closed -$626K 1554
2017
Q3
$626K Buy
+19,630
New +$600K 0.03% 739

Other funds holding MEDP

A.R.T. Advisors's MEDP Position: Q4 2019 in Review

A.R.T. Advisors sold out of Medpace (MEDP) in Q4 2019, closing a stake of 8,933 shares — an estimated $751K sold.

A.R.T. Advisors first reported a position in MEDP in Q3 2017 and held it in 5 quarters. The position peaked at $2.98M in Q3 2018. 250 funds tracked by Wall St. Rank hold MEDP as of Q4 2019.

  • A.R.T. Advisors reported no remaining Medpace position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 8,933 Medpace shares in Q4 2019, an estimated $751K.
  • A.R.T. Advisors first reported a position in Medpace in Q3 2017 and held it in 5 quarters.
  • A.R.T. Advisors's Medpace position peaked at $2.98M in Q3 2018.
  • 250 funds tracked by Wall St. Rank held Medpace as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.